Page last updated: 2024-12-07

thoron (reagent)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thoron (reagent): indicator for microtitration of sulfate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

aspan: a silicocarboxyl dental cement [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77270
SCHEMBL ID8649094
MeSH IDM0059693
PubMed CID77269
SCHEMBL ID416050
SCHEMBL ID4950631
MeSH IDM0059693

Synonyms (56)

Synonym
thoron (reagent)
2,7-naphthalenedisulfonic acid, 4-[(2-arsonophenyl)azo]-3-hydroxy-
132-33-2
unii-622f4knw84
4-((2-arsonophenyl)azo)-3-hydroxy-2,7-naphthalenedisulfonic acid
4-((2-arsonophenyl)azo)-3-hydroxynaphthalene-2,7-disulphonic acid
2,7-naphthalenedisulfonic acid, 4-(2-(2-arsonophenyl)diazenyl)-3-hydroxy-
2,7-naphthalenedisulfonic acid, 4-((2-arsonophenyl)azo)-3-hydroxy-
einecs 205-058-2
622f4knw84 ,
DTXSID9059624
SCHEMBL8649094
thorin sodium
4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid
2,7-naphthalenedisulfonic acid, 4-[2-(2-arsonophenyl)diazenyl]-3-hydroxy-
(4z)-4-[(2-arsonophenyl)hydrazinylidene]-3-oxo-naphthalene-2,7-disulfonic acid
4-[2-(2-arsonophenyl)diazenyl]-3-hydroxy-2,7-naphthalenedisulfonic acid
benzenearsonic acid, o-(2-hydroxy-3,6-disulfo-1-naphthylazo)-
arans
1-[(2-arsonophenyl)azo]-2-hydroxy-3,6-naphthalenedisulfonic acid
thorin free acid
naphtharson
disodium 4-((o-arsonophenyl)azo)-3-hydroxynaphthalene-2,7-disulphonate
nsc 148365
unii-lfp7cnk4m5
4-((2-arsonophenyl)azo)-3-hydroxy-2,7-naphthalenedisulfonic acid, disodium salt
lfp7cnk4m5 ,
einecs 222-993-1
thoron
nsc-148365
3688-92-4
thorin
thorin 1
H0240
1-(2-arsonophenylazo)-2-naphthol-3,6-disulfonic acid disodium salt
disodium 1-(2-arsonophenylazo)-2-naphthol-3,6-disulfonate
aspan
2-(2-hydroxy-3,6-disulfo-1-naphthylazo)benzenearsonic acid disodium salt
disodium (4e)-4-[(2-arsonophenyl)hydrazinylidene]-3-oxonaphthalene-2,7-disulfonate
disodium (4e)-4-[(2-arsonophenyl)hydrazinylidene]-3-oxidanylidene-naphthalene-2,7-disulfonate
A823442
AKOS015903215
thoronol
SCHEMBL416050
SCHEMBL4950631
J-610046
mfcd00003888
thorin i
DTXSID20893911
Q416786
sodium (e)-4-((2-arsonophenyl)diazenyl)-3-hydroxynaphthalene-2,7-disulfonate
disodium;4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate
2-[3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol hydrochoride[( inverted exclamation marka)tolterodine hydrochoride]
2,7-naphthalenedisulfonic acid, 4-((2-arsonophenyl)azo)-3-hydroxy-, disodium salt
2,7-naphthalenedisulfonic acid, 4-((o-arsonophenyl)azo)-3-hydroxy-, disodium salt
2,7-naphthalenedisulfonic acid, 4-[2-(2-arsonophenyl)diazenyl]-3-hydroxy-, sodium salt (1:2)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's1 (8.33)18.2507
2000's0 (0.00)29.6817
2010's3 (25.00)24.3611
2020's6 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]